GL1X · GenesisL1 explorer

MolNFT v1 · #26661 · protein

Crystallographic studies on two bioisosteric analogues, N-acetyl-beta- D-glucopyranosylamine and N-trifluoroacetyl-beta-D- glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase

1WW2 · Glycogen phosphorylase, muscle form: “Crystallographic studies on two bioisosteric analogues, N-acetyl-beta- D-glucopyranosylamine and…”. X-ray diffraction, 2 ligands (NBG, PLP), 15 pockets (best druggability 0.85). MolNFT v1 #26661…

PDB
1WW2
Type
protein
Length
817 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, muscle form
EC
2.4.1.1
UniProt
P00489
Ligands
NBG, PLP
Pockets
15 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase, muscle form (EC 2.4.1.1)protein81752% helix, 15% strandP00489

Ligands and binding sites

  • NBG · N-acetyl-beta-D-glucopyranosylamine · ligand · chains A
  • PLP · Pyridoxal-5'-phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12920.850.9550NBG, PLP
2940.720.9429empty
32590.690.8434empty
41170.520.8220empty
51760.520.7824empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1WW2 · Crystallographic studies on two bioisosteric analogues… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.